Tendinitis Treatment Market - Americas & Europe forecast till 2030

Tendinitis Treatment Market Research Report Information: By Type (Achilles Tendinitis, Supraspinatus Tendinitis, Tennis or Golfer's Elbow, De Quervain's Tenosynovitis), By Treatment (Diagnosis, Therapy, Shock Wave Therapy or Surgery, Medical Devices, Devices), By End User (Hospitals & Clinics, Medical Research Centers, Academic Institutes) - Americas & Europe Forecast till 2030

ID: MRFR/Pharma/3789-CR | 128 Pages | Author: Rahul Gotadki | January 2018         

1 Report Prologue

2 Market Introduction

2.1 Definition 17

2.2 Scope of Study 17

2.3 Research Objective 17

2.4 Assumptions & Limitations 18

2.4.1 Assumptions 18

2.4.2 Limitations 18

2.5 Market Structure 18

3 Research Methodology

3.1 Primary Research Methodology 20

3.2 Secondary Research Methodology 21

3.3 Market Share Analysis 21

3.4 Market Pricing Approach 21

4 Market Dynamics

4.1 Introduction 22

4.2 Drivers 23

4.2.1 Increasing prevalence of sports injuries (weightage 35%) 23

4.2.2 Increasing geriatric population (weightage 30%) 24

4.2.3 Increasing prevalence of patients suffering from diabetes and rheumatoid

arthritis (weightage 35%) 25

4.3 Restraints 26

4.3.1 Side effects of the treatment 26

4.4 Opportunity 27

4.5 Mega Trends 27

4.6 Macroeconomic Indicators 27

4.7 Number of patients not seeking treatment 28

4.8 Product opportunity 29

4.8.1 Introduction 29

4.8.2 Medical Bands 29

4.8.2.1 Disadvantages 29

4.8.2.2 Product Opportunity 29

4.8.3 OTC drugs 29

4.8.3.1 Disadvantages 30

4.8.3.2 Product Opportunity 30

4.8.4 Novel Treatment Options 30

4.8.4.1 Eccentric exercises 30

4.8.4.2 Intratissue Percutaneous Electrolysis 30

4.8.4.3 Sclerosant Injections 30

4.8.4.4 Extracorporeal Shock Wave Therapy 31

4.8.4.5 Ayurvedic Treatment for Tendinitis 31

4.8.4.6 Stem Cells 31

5 Market Factor Analysis

5.1 Porters Five forces Model 32

5.1.1 Bargaining power of suppliers 33

5.1.2 Bargaining power of buyers 33

5.1.3 Threat of new entrants 33

5.1.4 Threat of substitutes 33

5.1.5 Intensity of rivalry 34

5.2 Value Chain Analysis 34

5.2.1 R&D 34

5.2.2 Manufacturing 35

5.2.3 Distribution & sales 35

5.2.4 Post-sales monitoring 35

5.3 Demand & Supply: Gap Analysis 36

5.4 Pricing Analysis 36

5.5 Investment Opportunity Analysis 36

6 Americas & Europe Tendinitis Market, by Type

6.1 Introductions 37

6.2 Tennis or Golfer's Elbow 39

6.3 Achilles Tendinitis 40

6.4 Supraspinatus Tendinitis 41

6.5 De Quervain's Stenosing Tenosynovitis 42

6.6 Others 42

7 Americas & Europe Tendinitis Market, by Treatment

7.1 Introductions 43

7.2 Therapy 47

7.3 Diagnosis 48

7.4 Medical Devices 49

7.5 Others 49

8 Americas & Europe Tendinitis Market, by End User

8.1 Introductions 50

8.2 Hospitals & Clinics 51

8.3 Medical Research Center 52

8.4 Academic Institute 52

8.5 Others 53

9 Americas & Europe Tendinitis Market, by Region

9.1 Introductions 54

9.2 Americas 55

9.2.1 North America 60

9.2.1.1 U.S. 64

9.2.1.2 Canada 68

9.2.2 South Americas 72

9.3 Europe 77

9.3.1 Western Europe 82

9.3.1.1 Germany 86

9.3.1.2 France 90

9.3.1.3 U.K. 94

9.3.1.4 Italy 98

9.3.1.5 Spain 102

9.3.1.6 Rest of Western Europe 106

9.3.2 Eastern Europe 110

10 Company Landscape

10.1 Introduction 115

10.2 Company Share Analysis 115

10.3 Key Developments 116

11 Company Profiles

11.1 Abbott 118

11.1.1 Company Overview 118

11.1.2 Financials 118

11.1.3 Products 118

11.1.4 Strategy 118

11.1.5 Key Developments 118

11.2 Pfizer Inc. 119

11.2.1 Company Overview 119

11.2.2 Financials 119

11.2.3 Products 119

11.2.4 Strategy 119

11.2.5 Key Developments 119

11.3 AstraZeneca 120

11.3.1 Company Overview 120

11.3.2 Financials 120

11.3.3 Products 120

11.3.4 Strategy 120

11.3.5 Key Developments 120

11.4 Bayer 121

11.4.1 Company Overview 121

11.4.2 Financials 121

11.4.3 Products 121

11.4.4 Strategy 121

11.4.5 Key Developments 121

11.5 Merck & Co. Inc. 122

11.5.1 Company Overview 122

11.5.2 Financials 122

11.5.3 Products 122

11.5.4 Strategy 122

11.5.5 Key Developments 122

11.6 GlaxoSmithKline plc 123

11.6.1 Company Overview 123

11.6.2 Financials 123

11.6.3 Products 123

11.6.4 Strategy 123

11.6.5 Key Developments 123

11.7 Teva Pharmaceutical Industries 124

11.7.1 Company Overview 124

11.7.2 Financials 124

11.7.3 Products 124

11.7.4 Strategy 124

11.7.5 Key Developments 124

11.8 Boehringer Ingelheim 125

11.8.1 Company Overview 125

11.8.2 Financials 125

11.8.3 Products 125

11.8.4 Strategy 125

11.8.5 Key Developments 125

12 Conclusion

13 Appendix

13.1 Discussion Blue Print 128

13.2 References 130

14 List of Tables

TABLE 1 PRIMARY INTERVIEWS 20

TABLE 2 NUMBER OF PATIENTS NOT SEEKING TREATMENT 28

TABLE 3 AMERICAS & EUROPE TENDINITIS MARKET BY TYPE, 2020 TO 2027 (USD MILLION) 38

TABLE 4 AMERICAS & EUROPE TENNIS OR GOLFER'S ELBOW MARKET BY REGION, 2020 TO 2027 (USD MILLION) 39

TABLE 5 AMERICAS & EUROPE ACHILLES TENDINITIS MARKET BY REGION, 2020 TO 2027 (USD MILLION) 40

TABLE 6 AMERICAS & EUROPE SUPRASPINATUS TENDINITIS MARKET BY REGION, 2020 TO 2027 (USD MILLION) 41

TABLE 7 AMERICAS & EUROPE DE QUERVAIN'S STENOSING TENOSYNOVITIS MARKET BY REGION,

2020 TO 2027 (USD MILLION) 42

TABLE 8 AMERICAS & EUROPE OTHERS MARKET BY REGION, 2020 TO 2027 (USD MILLION) 42

TABLE 9 AMERICAS & EUROPE TENDINITIS MARKET BY TREATMENT, 2020 TO 2027 (USD MILLION) 44

TABLE 10 AMERICAS & EUROPE TENDINITIS MARKET FOR THERAPY BY TYPE, 2020 TO 2027 (USD MILLION) 44

TABLE 11 AMERICAS & EUROPE TENDINITIS MARKET FOR NON-PHARMACOLOGICAL BY TYPE,

2020 TO 2027 (USD MILLION) 45

TABLE 12 AMERICAS & EUROPE TENDINITIS MARKET FOR PHARMACOLOGICAL BY TYPE,

2020 TO 2027 (USD MILLION) 45

TABLE 13 AMERICAS & EUROPE TENDINITIS MARKET FOR DIAGNOSIS BY TYPES, 2020 TO 2027 (USD MILLION) 46

TABLE 14 AMERICAS & EUROPE TENDINITIS MARKET FOR IMAGING TEST BY TYPES, 2020 TO 2027 (USD MILLION) 46

TABLE 15 AMERICAS & EUROPE THERAPY MARKET BY REGION, 2020 TO 2027 (USD MILLION) 48

TABLE 16 AMERICAS & EUROPE DIAGNOSIS MARKET BY REGION, 2020 TO 2027 (USD MILLION) 48

TABLE 17 AMERICAS & EUROPE MEDICAL DEVICES MARKET BY REGION, 2020 TO 2027 (USD MILLION) 49

TABLE 18 AMERICAS & EUROPE OTHERS MARKET BY REGION, 2020 TO 2027 (USD MILLION) 49

TABLE 19 AMERICAS & EUROPE TENDINITIS MARKET BY END USER, 2020 TO 2027 (USD MILLION) 51

TABLE 20 AMERICAS & EUROPE HOSPITALS & CLINICS MARKET BY REGION, 2020 TO 2027 (USD MILLION) 51

TABLE 21 AMERICAS & EUROPE MEDICAL RESEARCH CENTERS MARKET BY REGION, 2020 TO 2027 (USD MILLION) 52

TABLE 22 AMERICAS & EUROPE ACADEMIC INSTITUTES MARKET BY REGION, 2020 TO 2027 (USD MILLION) 52

TABLE 23 AMERICAS & EUROPE OTHERS MARKET BY REGION, 2020 TO 2027 (USD MILLION) 53

TABLE 24 AMERICAS & EUROPE TENDINITIS MARKET BY REGION, 2020 TO 2027 (USD MILLION) 54

TABLE 25 AMERICAS TENDINITIS MARKET BY REGION, 2020 TO 2027 (USD MILLION) 55

TABLE 26 AMERICAS TENDINITIS MARKET BY TYPE, 2020 TO 2027 (USD MILLION) 56

TABLE 27 AMERICAS TENDINITIS MARKET BY TREATMENT, 2020 TO 2027 (USD MILLION) 56

TABLE 28 AMERICAS TENDINITIS MARKET FOR DIAGNOSIS BY TYPE, 2020 TO 2027 (USD MILLION) 57

TABLE 29 AMERICAS TENDINITIS MARKET FOR IMAGING TEST BY TYPE, 2020 TO 2027 (USD MILLION) 57

TABLE 30 AMERICAS TENDINITIS MARKET FOR THERAPY BY TYPE, 2020 TO 2027 (USD MILLION) 57

TABLE 31 AMERICAS TENDINITIS MARKET FOR NON-PHARMACOLOGICAL BY TYPE, 2020 TO 2027 (USD MILLION) 58

TABLE 32 AMERICAS TENDINITIS MARKET FOR PHARMACOLOGICAL BY TYPE, 2020 TO 2027 (USD MILLION) 58

TABLE 33 AMERICAS TENDINITIS MARKET FOR MEDICAL DEVICES BY TYPE, 2020 TO 2027 (USD MILLION) 59

TABLE 34 AMERICAS TENDINITIS MARKET BY END USER, 2020 TO 2027 (USD MILLION) 59

TABLE 35 NORTH AMERICAS TENDINITIS MARKET BY REGION, 2020 TO 2027 (USD MILLION) 60

TABLE 36 NORTH AMERICAS TENDINITIS MARKET BY TYPE, 2020 TO 2027 (USD MILLION) 60

TABLE 37 NORTH AMERICAS TENDINITIS MARKET BY TREATMENT, 2020 TO 2027 (USD MILLION) 61

TABLE 38 NORTH AMERICAS TENDINITIS MARKET FOR DIAGNOSIS BY TYPE, 2020 TO 2027 (USD MILLION) 61

TABLE 39 NORTH AMERICAS TENDINITIS MARKET FOR IMAGING TEST BY TYPE, 2020 TO 2027 (USD MILLION) 61

TABLE 40 NORTH AMERICAS TENDINITIS MARKET FOR THERAPY BY TYPE, 2020 TO 2027 (USD MILLION) 62

TABLE 41 NORTH AMERICAS TENDINITIS MARKET FOR NON-PHARMACOLOGICAL BY TYPE,

2020 TO 2027 (USD MILLION) 62

TABLE 42 NORTH AMERICAS TENDINITIS MARKET FOR PHARMACOLOGICAL BY TYPE, 2020 TO 2027 (USD MILLION) 63

TABLE 43 NORTH AMERICAS TENDINITIS MARKET FOR MEDICAL DEVICES BY TYPE, 2020 TO 2027 (USD MILLION) 63

TABLE 44 NORTH AMERICAS TENDINITIS MARKET BY END USER, 2020 TO 2027 (USD MILLION) 64

TABLE 45 U.S. TENDINITIS MARKET BY TYPE, 2020 TO 2027 (USD MILLION) 64

TABLE 46 U.S. TENDINITIS MARKET BY TREATMENT, 2020 TO 2027 (USD MILLION) 65

TABLE 47 U.S. TENDINITIS MARKET FOR DIAGNOSIS BY TYPE, 2020 TO 2027 (USD MILLION) 65

TABLE 48 U.S. TENDINITIS MARKET FOR IMAGING TEST BY TYPE, 2020 TO 2027 (USD MILLION) 65

TABLE 49 U.S. TENDINITIS MARKET FOR THERAPY BY TYPE, 2020 TO 2027 (USD MILLION) 66

TABLE 50 U.S. TENDINITIS MARKET FOR NON-PHARMACOLOGICAL BY TYPE, 2020 TO 2027 (USD MILLION) 66

TABLE 51 U.S. TENDINITIS MARKET FOR PHARMACOLOGICAL BY TYPE, 2020 TO 2027 (USD MILLION) 67

TABLE 52 U.S. TENDINITIS MARKET FOR MEDICAL DEVICES BY TYPE, 2020 TO 2027 (USD MILLION) 67

TABLE 53 U.S. TENDINITIS MARKET BY END USER, 2020 TO 2027 (USD MILLION) 68

TABLE 54 CANADA TENDINITIS MARKET BY TYPE, 2020 TO 2027 (USD MILLION) 68

TABLE 55 CANADA TENDINITIS MARKET BY TREATMENT, 2020 TO 2027 (USD MILLION) 69

TABLE 56 CANADA TENDINITIS MARKET FOR DIAGNOSIS BY TYPE, 2020 TO 2027 (USD MILLION) 69

TABLE 57 CANADA TENDINITIS MARKET FOR IMAGING TEST BY TYPE, 2020 TO 2027 (USD MILLION) 69

TABLE 58 CANADA TENDINITIS MARKET FOR THERAPY BY TYPE, 2020 TO 2027 (USD MILLION) 70

TABLE 59 CANADA TENDINITIS MARKET FOR NON-PHARMACOLOGICAL BY TYPE, 2020 TO 2027 (USD MILLION) 70

TABLE 60 CANADA TENDINITIS MARKET FOR PHARMACOLOGICAL BY TYPE, 2020 TO 2027 (USD MILLION) 71

TABLE 61 CANADA TENDINITIS MARKET FOR MEDICAL DEVICES BY TYPE, 2020 TO 2027 (USD MILLION) 71

TABLE 62 CANADA TENDINITIS MARKET BY END USER, 2020 TO 2027 (USD MILLION) 72

TABLE 63 SOUTH AMERICAS TENDINITIS MARKET BY TYPE, 2020 TO 2027 (USD MILLION) 72

TABLE 64 SOUTH AMERICAS TENDINITIS MARKET BY TREATMENT, 2020 TO 2027 (USD MILLION) 73

TABLE 65 SOUTH AMERICAS TENDINITIS MARKET FOR DIAGNOSIS BY TYPE, 2020 TO 2027 (USD MILLION) 73

TABLE 66 SOUTH AMERICAS TENDINITIS MARKET FOR IMAGING TEST BY TYPE, 2020 TO 2027 (USD MILLION) 73

TABLE 67 SOUTH AMERICAS TENDINITIS MARKET FOR THERAPY BY TYPE, 2020 TO 2027 (USD MILLION) 74

TABLE 68 SOUTH AMERICAS TENDINITIS MARKET FOR NON-PHARMACOLOGICAL BY TYPE,

2020 TO 2027 (USD MILLION) 74

TABLE 69 SOUTH AMERICAS TENDINITIS MARKET FOR PHARMACOLOGICAL BY TYPE, 2020 TO 2027 (USD MILLION) 75

TABLE 70 SOUTH AMERICAS TENDINITIS MARKET FOR MEDICAL DEVICES BY TYPE, 2020 TO 2027 (USD MILLION) 75

TABLE 71 SOUTH AMERICAS TENDINITIS MARKET BY END USER, 2020 TO 2027 (USD MILLION) 76

TABLE 72 EUROPE TENDINITIS MARKET BY REGION, 2020 TO 2027 (USD MILLION) 77

TABLE 73 EUROPE TENDINITIS MARKET BY TYPE, 2020 TO 2027 (USD MILLION) 78

TABLE 74 EUROPE TENDINITIS MARKET BY TREATMENT, 2020 TO 2027 (USD MILLION) 78

TABLE 75 EUROPE TENDINITIS MARKET FOR DIAGNOSIS BY TYPE, 2020 TO 2027 (USD MILLION) 79

TABLE 76 EUROPE TENDINITIS MARKET FOR IMAGING TEST BY TYPE, 2020 TO 2027 (USD MILLION) 79

TABLE 77 EUROPE TENDINITIS MARKET FOR THERAPY BY TYPE, 2020 TO 2027 (USD MILLION) 79

TABLE 78 EUROPE TENDINITIS MARKET FOR NON-PHARMACOLOGICAL BY TYPE, 2020 TO 2027 (USD MILLION) 80

TABLE 79 EUROPE TENDINITIS MARKET FOR PHARMACOLOGICAL BY TYPE, 2020 TO 2027 (USD MILLION) 80

TABLE 80 EUROPE TENDINITIS MARKET FOR MEDICAL DEVICES BY TYPE, 2020 TO 2027 (USD MILLION) 81

TABLE 81 EUROPE TENDINITIS MARKET BY END USER, 2020 TO 2027 (USD MILLION) 81

TABLE 82 WESTERN EUROPE TENDINITIS MARKET BY REGION, 2020 TO 2027 (USD MILLION) 82

TABLE 83 WESTERN EUROPE TENDINITIS MARKET BY TYPE, 2020 TO 2027 (USD MILLION) 82

TABLE 84 WESTERN EUROPE TENDINITIS MARKET BY TREATMENT, 2020 TO 2027 (USD MILLION) 83

TABLE 85 WESTERN EUROPE TENDINITIS MARKET FOR DIAGNOSIS BY TYPE, 2020 TO 2027 (USD MILLION) 83

TABLE 86 WESTERN EUROPE TENDINITIS MARKET FOR IMAGING TEST BY TYPE, 2020 TO 2027 (USD MILLION) 83

TABLE 87 WESTERN EUROPE TENDINITIS MARKET FOR THERAPY BY TYPE, 2020 TO 2027 (USD MILLION) 84

TABLE 88 WESTERN EUROPE TENDINITIS MARKET FOR NON-PHARMACOLOGICAL BY TYPE,

2020 TO 2027 (USD MILLION) 84

TABLE 89 WESTERN EUROPE TENDINITIS MARKET FOR PHARMACOLOGICAL BY TYPE, 2020 TO 2027 (USD MILLION) 85

TABLE 90 WESTERN EUROPE TENDINITIS MARKET FOR MEDICAL DEVICES BY TYPE, 2020 TO 2027 (USD MILLION) 85

TABLE 91 WESTERN EUROPE TENDINITIS MARKET BY END USER, 2020 TO 2027 (USD MILLION) 86

TABLE 92 GERMANY TENDINITIS MARKET BY TYPE, 2020 TO 2027 (USD MILLION) 86

TABLE 93 GERMANY TENDINITIS MARKET BY TREATMENT, 2020 TO 2027 (USD MILLION) 87

TABLE 94 GERMANY TENDINITIS MARKET FOR DIAGNOSIS BY TYPE, 2020 TO 2027 (USD MILLION) 87

TABLE 95 GERMANY TENDINITIS MARKET FOR IMAGING TEST BY TYPE, 2020 TO 2027 (USD MILLION) 87

TABLE 96 GERMANY TENDINITIS MARKET FOR THERAPY BY TYPE, 2020 TO 2027 (USD MILLION) 88

TABLE 97 GERMANY TENDINITIS MARKET FOR NON-PHARMACOLOGICAL BY TYPE, 2020 TO 2027 (USD MILLION) 88

TABLE 98 GERMANY TENDINITIS MARKET FOR PHARMACOLOGICAL BY TYPE, 2020 TO 2027 (USD MILLION) 89

TABLE 99 GERMANY TENDINITIS MARKET FOR MEDICAL DEVICES BY TYPE, 2020 TO 2027 (USD MILLION) 89

TABLE 100 GERMANY TENDINITIS MARKET BY END USER, 2020 TO 2027 (USD MILLION) 90

TABLE 101 FRANCE TENDINITIS MARKET BY TYPE, 2020 TO 2027 (USD MILLION) 90

TABLE 102 FRANCE TENDINITIS MARKET BY TREATMENT, 2020 TO 2027 (USD MILLION) 91

TABLE 103 FRANCE TENDINITIS MARKET FOR DIAGNOSIS BY TYPE, 2020 TO 2027 (USD MILLION) 91

TABLE 104 FRANCE TENDINITIS MARKET FOR IMAGING TEST BY TYPE, 2020 TO 2027 (USD MILLION) 91

TABLE 105 FRANCE TENDINITIS MARKET FOR THERAPY BY TYPE, 2020 TO 2027 (USD MILLION) 92

TABLE 106 FRANCE TENDINITIS MARKET FOR NON-PHARMACOLOGICAL BY TYPE, 2020 TO 2027 (USD MILLION) 92

TABLE 107 FRANCE TENDINITIS MARKET FOR PHARMACOLOGICAL BY TYPE, 2020 TO 2027 (USD MILLION) 93

TABLE 108 FRANCE TENDINITIS MARKET FOR MEDICAL DEVICES BY TYPE, 2020 TO 2027 (USD MILLION) 93

TABLE 109 FRANCE TENDINITIS MARKET BY END USER, 2020 TO 2027 (USD MILLION) 94

TABLE 110 U.K. TENDINITIS MARKET BY TYPE, 2020 TO 2027 (USD MILLION) 94

TABLE 111 U.K. TENDINITIS MARKET BY TREATMENT, 2020 TO 2027 (USD MILLION) 95

TABLE 112 U.K. TENDINITIS MARKET FOR DIAGNOSIS BY TYPE, 2020 TO 2027 (USD MILLION) 95

TABLE 113 U.K. TENDINITIS MARKET FOR IMAGING TEST BY TYPE, 2020 TO 2027 (USD MILLION) 95

TABLE 114 U.K. TENDINITIS MARKET FOR THERAPY BY TYPE, 2020 TO 2027 (USD MILLION) 96

TABLE 115 U.K. TENDINITIS MARKET FOR NON-PHARMACOLOGICAL BY TYPE, 2020 TO 2027 (USD MILLION) 96

TABLE 116 U.K. TENDINITIS MARKET FOR PHARMACOLOGICAL BY TYPE, 2020 TO 2027 (USD MILLION) 97

TABLE 117 U.K. TENDINITIS MARKET FOR MEDICAL DEVICES BY TYPE, 2020 TO 2027 (USD MILLION) 97

TABLE 118 U.K. TENDINITIS MARKET BY END USER, 2020 TO 2027 (USD MILLION) 98

TABLE 119 ITALY TENDINITIS MARKET BY TYPE, 2020 TO 2027 (USD MILLION) 98

TABLE 120 ITALY TENDINITIS MARKET BY TREATMENT, 2020 TO 2027 (USD MILLION) 99

TABLE 121 ITALY TENDINITIS MARKET FOR DIAGNOSIS BY TYPE, 2020 TO 2027 (USD MILLION) 99

TABLE 122 ITALY TENDINITIS MARKET FOR IMAGING TEST BY TYPE, 2020 TO 2027 (USD MILLION) 99

TABLE 123 ITALY TENDINITIS MARKET FOR THERAPY BY TYPE, 2020 TO 2027 (USD MILLION) 100

TABLE 124 ITALY TENDINITIS MARKET FOR NON-PHARMACOLOGICAL BY TYPE, 2020 TO 2027 (USD MILLION) 100

TABLE 125 ITALY TENDINITIS MARKET FOR PHARMACOLOGICAL BY TYPE, 2020 TO 2027 (USD MILLION) 101

TABLE 126 ITALY TENDINITIS MARKET FOR MEDICAL DEVICES BY TYPE, 2020 TO 2027 (USD MILLION) 101

TABLE 127 ITALY TENDINITIS MARKET BY END USER, 2020 TO 2027 (USD MILLION) 102

TABLE 128 SPAIN TENDINITIS MARKET BY TYPE, 2020 TO 2027 (USD MILLION) 102

TABLE 129 SPAIN TENDINITIS MARKET BY TREATMENT, 2020 TO 2027 (USD MILLION) 103

TABLE 130 SPAIN TENDINITIS MARKET FOR DIAGNOSIS BY TYPE, 2020 TO 2027 (USD MILLION) 103

TABLE 131 SPAIN TENDINITIS MARKET FOR IMAGING TEST BY TYPE, 2020 TO 2027 (USD MILLION) 103

TABLE 132 SPAIN TENDINITIS MARKET FOR THERAPY BY TYPE, 2020 TO 2027 (USD MILLION) 104

TABLE 133 SPAIN TENDINITIS MARKET FOR NON-PHARMACOLOGICAL BY TYPE, 2020 TO 2027 (USD MILLION) 104

TABLE 134 SPAIN TENDINITIS MARKET FOR PHARMACOLOGICAL BY TYPE, 2020 TO 2027 (USD MILLION) 105

TABLE 135 SPAIN TENDINITIS MARKET FOR MEDICAL DEVICES BY TYPE, 2020 TO 2027 (USD MILLION) 105

TABLE 136 SPAIN TENDINITIS MARKET BY END USER, 2020 TO 2027 (USD MILLION) 106

TABLE 137 REST OF WESTERN EUROPE TENDINITIS MARKET BY TYPE, 2020 TO 2027 (USD MILLION) 106

TABLE 138 REST OF WESTERN EUROPE TENDINITIS MARKET BY TREATMENT, 2020 TO 2027 (USD MILLION) 107

TABLE 139 REST OF WESTERN EUROPE TENDINITIS MARKET FOR DIAGNOSIS BY TYPE, 2020 TO 2027 (USD MILLION) 107

TABLE 140 REST OF WESTERN EUROPE TENDINITIS MARKET FOR IMAGING TEST BY TYPE,

2020 TO 2027 (USD MILLION) 107

TABLE 141 REST OF WESTERN EUROPE TENDINITIS MARKET FOR THERAPY BY TYPE, 2020 TO 2027 (USD MILLION) 108

TABLE 142 REST OF WESTERN EUROPE TENDINITIS MARKET FOR NON-PHARMACOLOGICAL BY TYPE,

2020 TO 2027 (USD MILLION) 108

TABLE 143 REST OF WESTERN EUROPE TENDINITIS MARKET FOR PHARMACOLOGICAL BY TYPE,

2020 TO 2027 (USD MILLION) 109

TABLE 144 REST OF WESTERN EUROPE TENDINITIS MARKET FOR MEDICAL DEVICES BY TYPE,

2020 TO 2027 (USD MILLION) 109

TABLE 145 REST OF WESTERN EUROPE TENDINITIS MARKET BY END USER, 2020 TO 2027 (USD MILLION) 110

TABLE 146 EASTERN EUROPE TENDINITIS MARKET BY TYPE, 2020 TO 2027 (USD MILLION) 110

TABLE 147 EASTERN EUROPE TENDINITIS MARKET BY TREATMENT, 2020 TO 2027 (USD MILLION) 111

TABLE 148 EASTERN EUROPE TENDINITIS MARKET FOR DIAGNOSIS BY TYPE, 2020 TO 2027 (USD MILLION) 111

TABLE 149 EASTERN EUROPE TENDINITIS MARKET FOR IMAGING TEST BY TYPE, 2020 TO 2027 (USD MILLION) 111

TABLE 150 EASTERN EUROPE TENDINITIS MARKET FOR THERAPY BY TYPE, 2020 TO 2027 (USD MILLION) 112

TABLE 151 EASTERN EUROPE TENDINITIS MARKET FOR NON-PHARMACOLOGICAL BY TYPE,

2020 TO 2027 (USD MILLION) 112

TABLE 152 EASTERN EUROPE TENDINITIS MARKET FOR PHARMACOLOGICAL BY TYPE, 2020 TO 2027 (USD MILLION) 113

TABLE 153 EASTERN EUROPE TENDINITIS MARKET FOR MEDICAL DEVICES BY TYPE, 2020 TO 2027 (USD MILLION) 113

TABLE 154 EASTERN EUROPE TENDINITIS MARKET BY END USER, 2020 TO 2027 (USD MILLION) 114

15 List of Figures

FIGURE 1 AMERICAS & EUROPE TENDINITIS MARKET, BY TYPE, 2020 (%) 13

FIGURE 2 AMERICAS & EUROPE TENDINITIS MARKET, BY TREATMENT 2020 (%) 14

FIGURE 3 AMERICAS & EUROPE TENDINITIS MARKET, BY END USER, 2020 (%) 15

FIGURE 4 AMERICAS & EUROPE TENDINITIS MARKET, BY REGION 2020 (%) 15

FIGURE 5 MARKET STRUCTURE OF AMERICAS & EUROPE TENDINITIS MARKET 18

FIGURE 6 RESEARCH METHODOLOGY 19

FIGURE 7 DRIVERS AND RESTRAINTS FOR THE TENDINITIS MARKET 22

FIGURE 8 PORTERS FIVE FORCES MODEL 32

FIGURE 9 VALUE CHAIN: TENDINITIS TREATMENT MARKET 34

FIGURE 10 AMERICAS & EUROPE TENDINITIS MARKET BY TYPE, 2020 & 2027 (USD MILLION) 37

FIGURE 11 AMERICAS & EUROPE TENDINITIS MARKET BY TREATMENT, 2020 & 2027 (USD MILLION) 43

FIGURE 12 AMERICAS & EUROPE TENDINITIS MARKET BY END USER, 2020 & 2027 (USD MILLION) 50

FIGURE 13 AMERICAS & EUROPE TENDINITIS MARKET BY REGION, 2020 (%) 54

FIGURE 14 AMERICAS AND EUROPE TENDINITIS COMPANY SHARE ANALYSIS, 2020 (%) 115

Leading companies partner with us for data-driven Insights.
Report List icon Report List icon Report List icon Report List icon Report List icon Report List icon Report List icon Report List icon Report List icon Report List icon Report List icon

Kindly complete the form below to receive a free sample of this Report

Please fill in Business Email for Quick Response
Invalid